NASDAQ:TNON

Tenon Medical (TNON) Stock Price, News & Analysis

$0.84
-0.01 (-1.18%)
(As of 05/6/2024 ET)
Today's Range
$0.83
$0.87
50-Day Range
$0.71
$1.45
52-Week Range
$0.71
$20.40
Volume
16,059 shs
Average Volume
193,915 shs
Market Capitalization
$3.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.00

Tenon Medical MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
256.7% Upside
$3.00 Price Target
Short Interest
Healthy
1.82% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.85 out of 5 stars

TNON stock logo

About Tenon Medical Stock (NASDAQ:TNON)

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as stabilizes and transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

TNON Stock Price History

TNON Stock News Headlines

This is the ONLY AI story you should be worried about
A.I. is creeping into every aspect of our daily lives… According to billion-dollar fund manager, Louis Navellier, it’s never been more important to A.I.-proof your wealth. He lays out three simple steps to take ASAP in his latest video.
Healthcare Stock Bid Up Before Opening Bell
This is the ONLY AI story you should be worried about
A.I. is creeping into every aspect of our daily lives… According to billion-dollar fund manager, Louis Navellier, it’s never been more important to A.I.-proof your wealth. He lays out three simple steps to take ASAP in his latest video.
Q4 2023 Tenon Medical Inc Earnings Call
Recap: Tenon Medical Q4 Earnings
Tenon Medical Inc TNON
Tenon Medical Reports Third Quarter 2023 Financial Results
Tenon Medical Passes FDA Level 2 Inspection
See More Headlines
Receive TNON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tenon Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/12/2024
Today
5/06/2024
Next Earnings (Confirmed)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:TNON
Fax
N/A
Employees
21
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$3.00
High Stock Price Target
$3.00
Low Stock Price Target
$3.00
Potential Upside/Downside
+257.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-15,580,000.00
Net Margins
-532.14%
Pretax Margin
-532.14%

Debt

Sales & Book Value

Annual Sales
$2.93 million
Book Value
$0.30 per share

Miscellaneous

Free Float
3,414,000
Market Cap
$3.13 million
Optionable
Not Optionable
Beta
2.21
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

TNON Stock Analysis - Frequently Asked Questions

Should I buy or sell Tenon Medical stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tenon Medical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" TNON shares.
View TNON analyst ratings
or view top-rated stocks.

What is Tenon Medical's stock price target for 2024?

1 equities research analysts have issued 12-month target prices for Tenon Medical's stock. Their TNON share price targets range from $3.00 to $3.00. On average, they expect the company's share price to reach $3.00 in the next year. This suggests a possible upside of 256.7% from the stock's current price.
View analysts price targets for TNON
or view top-rated stocks among Wall Street analysts.

How have TNON shares performed in 2024?

Tenon Medical's stock was trading at $1.58 on January 1st, 2024. Since then, TNON shares have decreased by 46.8% and is now trading at $0.8410.
View the best growth stocks for 2024 here
.

Are investors shorting Tenon Medical?

Tenon Medical saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 57,400 shares, a drop of 44.8% from the March 31st total of 104,000 shares. Based on an average trading volume of 254,100 shares, the short-interest ratio is currently 0.2 days. Currently, 1.8% of the shares of the company are sold short.
View Tenon Medical's Short Interest
.

When is Tenon Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our TNON earnings forecast
.

How were Tenon Medical's earnings last quarter?

Tenon Medical, Inc. (NASDAQ:TNON) issued its quarterly earnings data on Tuesday, March, 12th. The company reported ($0.68) EPS for the quarter. The company earned $0.81 million during the quarter. Tenon Medical had a negative net margin of 532.14% and a negative trailing twelve-month return on equity of 934.11%.

When did Tenon Medical IPO?

Tenon Medical (TNON) raised $16 million in an initial public offering (IPO) on Wednesday, April 27th 2022. The company issued 3,200,000 shares at $4.50-$5.50 per share.

How do I buy shares of Tenon Medical?

Shares of TNON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:TNON) was last updated on 5/7/2024 by MarketBeat.com Staff

From Our Partners